Health

Results: 13-24 of 8946

Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

Nabsys Announces Advancements in Detection of Repeat Contraction and Expansion Disorders Via Electronic Genome Mapping in Collaboration with Leading European Institutions

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements

KFSH Presents Applied Radiology AI Model at HLTH Europe 2026

Michael Dabrowski, Chief Executive Officer of Pelago Bioscience

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry

Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026

Azafaros to Present at BIO International Convention 2026

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026

KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia

KFSH Showcases Trusted AI as the Foundation for Scalable Healthcare Transformation at HLTH Europe 2026